Growth at Reasonable Price

Results

150

26 new

150 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
MDGL
US$507.56-5.8%49.8%US$11.1bUS$678.069.163.7%n/aPharmaceuticals & Biotech
NVDA
US$211.9411.5%18.1%US$5.1tUS$302.8332.222.8%0.5%Semiconductors
AXSM
New
US$212.17-6.7%105.5%US$10.9bUS$282.3215.457.0%n/aPharmaceuticals & Biotech
TVTX
US$56.020.8%224.9%US$5.2bUS$59.149.750.0%n/aPharmaceuticals & Biotech
COUR
New
US$6.104.3%-49.9%US$1.7bUS$8.172.0123.6%n/aConsumer Services
SNDX
US$19.08-2.8%51.8%US$1.7bUS$39.457.868.1%n/aPharmaceuticals & Biotech
HIMS
New
US$32.169.7%-42.1%US$7.1bUS$29.233.168.5%n/aHealthcare
PICS
US$13.128.2%n/aUS$1.7bUS$19.957.523.3%n/aDiversified Financials
APP
US$419.700.4%11.1%US$136.4bUS$656.2036.021.7%n/aMedia
ANAB
US$55.135.8%132.7%US$1.6bUS$87.097.048.1%40.8%Pharmaceuticals & Biotech
FPS
US$39.4021.6%n/aUS$11.0bUS$59.90563.643.4%n/aCapital Goods
ARDX
US$5.01-1.5%-2.3%US$1.2bUS$16.302.956.0%n/aPharmaceuticals & Biotech
IONS
US$55.07-0.4%27.9%US$9.1bUS$89.3310.567.9%n/aPharmaceuticals & Biotech
WBI
US$33.464.7%n/aUS$4.2bUS$34.572.577.2%0.6%Energy
AGBK
US$7.00-1.7%n/aUS$1.1bUS$13.211.228.5%n/aBanks
ORCL
US$145.7421.5%-43.0%US$408.6bUS$248.1524.724.2%1.4%Software
EROC
US$11.5013.9%n/aUS$3.0bUS$22.632.956.3%n/aCapital Goods
TYGO
US$2.0432.5%59.4%US$156.4mUS$6.8545.943.3%n/aCapital Goods
FLEX
US$126.7111.9%150.7%US$43.4bUS$160.5048.144.9%n/aTech
COMP
US$12.001.0%45.5%US$8.8bUS$14.33618.336.6%n/aReal Estate Management and Development
LKNC.Y
US$37.0115.3%-2.6%US$12.0bUS$47.6321.323.1%n/aConsumer Services
ABEO
US$6.8213.3%5.4%US$364.2mUS$19.715.932.9%n/aPharmaceuticals & Biotech
PTHS
US$26.70-3.9%27.1%US$93.3mUS$57.713.465.9%n/aPharmaceuticals & Biotech
CAPR
US$4.17-36.5%-45.6%US$243.2mUS$4.380.963.7%n/aPharmaceuticals & Biotech
Page 1 of 5